https://www.selleckchem.com/pr....oducts/dibutyryl-cam
Selective amygdalohippocampectomy (SelAH) is designed to treat medically refractory mesial temporal lobe epilepsy with reduced morbidity compared to standard anterior temporal lobectomy. At our institution, we perform SelAH via a transcortical approach via small corticectomy in the middle temporal gyrus. To discuss the surgical anatomy and nuances of SelAH, share our institutional experience, and perform a review of literature. Institutional experience was recorded by collecting demographic and outcome data from 1999